Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 4/2020

Open Access 01-08-2020 | Alopecia | Review

Platelet-Rich Plasma and its Use for Cicatricial and Non-Cicatricial Alopecias: A Narrative Review

Authors: Rubina Alves, Ramon Grimalt

Published in: Dermatology and Therapy | Issue 4/2020

Login to get access

Abstract

The concept and description of platelet-rich plasma (PRP) started in the field of hematology and is being extensively used in other fields of medicine. Interest in the application of PRP has been increasing in dermatology, such as in tissue regeneration, wound healing, scar revision, skin-rejuvenating effects, and alopecia. PRP is an autologous blood product containing high concentrations of platelets in a small volume of plasma. Different preparations of PRP may lead to different volumes of PRP, platelet concentration, and presence or absence of leukocytes. PRP is being used as a new therapy for some types of non-cicatricial alopecia such as androgenetic alopecia (AGA) and alopecia areata (AA) and, recently, new insights refer to the possibility of action in the field of cicatricial alopecia, like lichen planopillaris (LPP) and frontal fibrosing alopecia (FFA). This article aims to identify the major indications for the application of PRP in the field of hair disorders, including non-cicatricial and cicatricial alopecia.
Literature
1.
Kramer ME, Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia. J Cosmet Dermatol. 2018;17:666–71.PubMed
2.
Andia I, Abate M. Platelet rich plasma: underlying biology and clinical correlates. Regen Med. 2013;8(5):645–58.PubMed
3.
Andia I. Platelet-rich plasma Biology. In: Alves R, Grimalt R, editors. Clinical indications and treatment protocols with platelet-rich plasma in dermatology. Barcelona: Ediciones Mayo; 2016. p. 3–15.
4.
Conde Montero E, Fernández Santos ME, Suárez FR. Platelet-rich plasma: applications in dermatology. Actas Dermosifiliogr. 2015;106(2):104–11.PubMed
5.
Lynch MD, Bashir S. Applications of platelet-rich plasma in dermatology: a critical appraisal of the literature. J Dermatolog Treat. 2016;27(3):285–9.PubMed
6.
Andia I, Rubio-Azpeitia E, Martin JI, Abate M. Current concepts and translational uses of platelet rich plasma biotechnology. In: Ekinci D, editor. Biotechnology. London: InTech; 2015.
7.
Li ZJ, Choi HI, Choi DK, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg. 2012;38:1040–6.PubMed
8.
Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, Monstrey S. The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2013;66:301–11.PubMed
9.
Cobos R, Aizpuru F, Parraza N, Anitua E, Orive G. Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers. Curr Pharm Biotechnol. 2015;16:630–4.PubMed
10.
Sclafani AP, Azzi J. Platelet preparations for use in facial rejuvenation and wound healing: a critical review of current literature. Aesthec Plast Surg. 2015;39:495–505.
11.
Salazar-Álvarez AE, Riera-del-Moral LF, García-Arranz M, Alvarez-García J, Concepción-Rodriguez NA, Riera-de-Cubas L. Use of platelet-rich plasma in the healing of chronic ulcers of the lower extremity. Actas Dermosifiliogr. 2014;105:597–604.PubMed
12.
Conde ME. PRP in wound healing. In: Alves R, Grimalt R, editors. Clinical indications and treatment protocols with platelet-rich plasma in dermatology. Barcelona: Ediciones Mayo; 2016. p. 59–72.
13.
Picard F, Hersant B, Bosc R, Meningaud JP. Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds”, “burns”, and “laser therapies”: a review and a proposal of a quality criteria checklist for further studies. Wound Repair Regen. 2015;23:163–70.PubMed
14.
Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord. 2018;4(1):18–24.PubMed
15.
Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2018;5(1):46–51.PubMedPubMedCentral
16.
Wroblewski AP, Melia HJ, Wright VJ. Application of platelet-rich plasma to enhance tissue repair. Oper Tech Orthop. 2010;20:98–105.
17.
Alves R, Grimalt R. A randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42:491–7.PubMed
18.
Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg. 2006;118:1458–66.PubMed
19.
Takikawa M, Nakamura S, Nakamura S, Ishirara M, Kishimoto S, Sasaki K. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011;37:1721–9.PubMed
20.
Gupta AK, Carviel J. A mechanistic model of platelet-rich plasma treatment for androgenetic alopecia. Dermatol Surg. 2016;42(12):1335–9.PubMed
21.
Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappa B inhibition via HGF. J Cell Physiol. 2010;225(3):757–66.PubMed
22.
Walshe TE, Saint-Geniez M, Maharaj ASR, Sekiyama E, Maldonado AE, D’Amore PA. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One. 2009;4(4):e5149.PubMedPubMedCentral
23.
Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol. 2011;26(Suppl 1):188–202.PubMed
24.
Soudriet GM, He J, Trucco M, Mars WM, Piganelli JD. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One. 2010;5(11):e15384.
25.
Rigopoulos D, Stamatios G, Ioannides D. Primary scarring alopecias. Curr Probl Dermatol. 2015;47:76–86.PubMed
26.
Trink A, Sorbellini E, Bezzola P, et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013;169:690–4.PubMed
27.
Cervelli V, Garcovich S, Bielli A, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014;2014:760709.PubMedPubMedCentral
28.
Greco J, Brandt R. The effects of autologous platelet rich plasma and various growth factors on non- transplanted miniaturized hair. Hair Transplant Forum Int. 2009;19:49–50.
29.
Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40:1010–9.PubMed
30.
Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg. 2014;7:213–9.PubMedPubMedCentral
31.
Ferrando J, Fernández-Sartorio C, González de Cossío AC, Navarra E. Tratamiento de la alopecia androgenetica con factores de crecimiento plaquetario. Monogr Dermatol. 2016;42:491–7.
32.
Maria-Angeliki G, Alexandros-Efstratios K, Dimitris R, Konstantinos K. Platelet-rich plasma as a potential treatment for noncicatricial alopecias. Int J Trichol. 2015;7(2):54–63.
33.
Gupta AK, Cole J, Deutsch DP, et al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol Surg. 2019;10:1262–73.
34.
Bruce AJ, Pincelli TP, Heckman MG, et al. A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women. Dermatol Surg. 2019;46:826–32.
35.
Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138(3):407–11.PubMed
36.
37.
Alves R. PRP in alopecia. In: Alves R, Grimalt R, editors. Clinical indications and treatment protocols with platelet-rich plasma in dermatology. Barcelona: Ediciones Mayo; 2016. p. 29–44.
38.
Alves R, Grimalt R. Hair loss in children. Curr Probl Dermatol. 2015;47:55–66.PubMed
39.
Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62:177–88.PubMed
40.
Bhat YJ, Sajad P, Hassan I. Etiopathogenesis of alopecia areata. Hair Ther Transplant. 2014;4:1–4.
41.
Albalat W, Ebrahim HM. Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata. J Cosmet Dermatol. 2019;00:1–7.
42.
Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol. 2005;52(2):287–90.PubMed
43.
Shreberk-Hassidim R, Ramot Y, Gilula Z, Zlotogorski A. A systematic review of pulse steroid therapy for alopecia areata. J Am Acad Dermatol. 2016;74(2):372–374.e5.PubMed
44.
Singh S. Role of platelet-rich plasma in chronic alopecia areata: our centre experience. Indian J Plast Surg. 2015;48(1):57–9.PubMedPubMedCentral
45.
Donovan J. Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP). JAAD Case Rep. 2015;1(5):305–7.PubMedPubMedCentral
46.
Khademi F, Tehranchinia Z, Abdollahimajd F, Younespour S, Kazemi-Bajestani SMR, Taheri K. The effect of platelet rich plasma on hair regrowth in patients with alopecia areata totalis: a clinical pilot study. Dermatol Ther. 2019;32:e12989.PubMed
47.
Dina Y, Aguh C. Use of platelet-rich plasma in cicatricial alopecia. Dermatol Surg. 2019;45(7):979–81.PubMed
48.
Bolanča Ž, Goren A, Getaldić-Švarc B, Vučić M, Šitum M. Platelet-rich plasma as a novel treatment for lichen planopillaris. Dermatol Ther. 2016;29(4):233–5.PubMed
49.
Jha AK, Vinay K, Zeeshan M, Roy PK, Chaudhary RKP, Priya A. Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil. J Cosmet Dermatol. 2019;00:1–6.
50.
Jha AK. Platelet-rich plasma as an adjunctive treatment in lichen planopilaris. J Am Acad Dermatol. 2019;80(5):e109–e110110.PubMed
51.
Chew AL, Bashir SJ, Wain EM, Fenton DA, Stefanato CM. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept. J Am Acad Dermatol. 2010;63:653–60.PubMed
52.
Porriño-Bustamante ML, Fernández-Pugnaire MA, Arias-Santiago S. A cross-sectional study of rosacea and risk factors in women with frontal fibrosing alopecia. Acta Derm Venereol. 2019;99:1099–104.PubMed
53.
Esteban-Lucía L, Molina-Ruiz AM, Requena L. Update on frontal fibrosing alopecia. Actas Dermo-Sifiliogr. 2017;108:293–304.
54.
55.
Starace M, Brandi N, Alessandrini A, Bruni F, Piraccini BM. Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre. J Eur Acad Dermatol Venereol. 2019;33:433–8.PubMed
56.
Strazzulla LC, Avila L, Li X, Lo Sicco K, Shapiro J. Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: a retrospective review of 92 cases. J Am Acad Dermatol. 2018;78:203–5.PubMed
57.
Özcan D, Tunçer Vural A, Özen Ö. Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report. Dermatol Ther. 2019;23:e13072.
Metadata
Title
Platelet-Rich Plasma and its Use for Cicatricial and Non-Cicatricial Alopecias: A Narrative Review
Authors
Rubina Alves
Ramon Grimalt
Publication date
01-08-2020
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 4/2020
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-020-00408-5

Other articles of this Issue 4/2020

Dermatology and Therapy 4/2020 Go to the issue

Original Research

Electrocautery Needling and the 308-nm Excimer Lamp: A Synergistic Combination for the Treatment of Stable Non-segmental Vitiligo

Original Research

Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production

Case Report

Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review

Case Series

Clinical Characteristics of 18 Patients with Psoriasis and Multiple Myeloma Identified Through Digital Health Crowdsourcing

Original Research

Cardiovascular Drug Use and Risk of Actinic Keratosis: A Case-Control Study

Original Research

Itch in Children with Type 1 Diabetes: A Cross-Sectional Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits